The poor photovoltaic performance of state‐of‐the‐art blends of poly[4,8‐bis[(2‐ethylhexyl)oxy]benzo[1,2‐b:4,5‐b′]dithiophene‐2,6‐diyl][3‐fluoro‐2‐[(2‐ethylhexyl)carbonyl]thieno[3,4‐b]thiophenediyl] (PTB7) and [6,6]‐phenyl‐C61‐butyric acid (PCBM) at large active layer thicknesses is studied using space‐charge‐limited current mobility and photovoltaic device measurements. The poor performance is found to result from relatively low electron mobility. This is attributed to the low tendency of PTB7 to aggregate, which reduces the ability of the fullerene to form a connected network. Increasing the PCBM content 60–80 wt% increases electron mobility and accordingly improves performance for thicker devices, resulting in a fill factor (FF) close to 0.6 at 300 nm. The result confirms that by improving only the connectivity of the fullerene phase, efficient electron and hole collection is possible for 300 nm‐thick PTB7:PCBM devices. Furthermore, it is shown that solvent additive 1,8‐diiodooctane (DIO), used in the highest efficiency PTB7:PCBM devices, does not improve the thickness dependence and, accordingly, does not lead to an increase in either hole or electron mobility or in the carrier lifetime. A key challenge for researchers is therefore to develop new methods to ensure connectivity in the fullerene phase in blends without relying on either a large excess of fullerene or strong aggregation of the polymer.
We examined the inhibitory mechanism of BRL37344, a beta-adrenoceptor agonist that is considered to be specific to beta(3)-subtype, on muscarinic receptor-mediated contraction of the rat urinary bladder smooth muscle. BRL37344 produced apparently biphasic concentration-relaxation curves in the urinary bladder smooth muscle contracted with carbachol (0.6 microM). The first and second phases had estimated p D(2) (-logEC(50)) values of 7.80+/-0.34 and 4.62+/-0.18, respectively ( n=6). The first component of the BRL37344 concentration-response curve was not affected by propranolol (1 microM), whereas it was inhibited by higher concentrations of the drug (10 microM or 30 microM). The second component was completely resistant to propranolol. On the other hand, BRL37344 produced monophasic concentration-relaxation of 30 mM KCl-precontracted urinary bladder smooth muscle with a p D(2) value of 8.34+/-0.18 ( n=6). Pretreatment of the urinary bladder smooth muscles with BRL37344 (30, 100 and 300 microM) significantly ( P<0.05) shifted the concentration-response curves for carbachol-induced contractions. In radioligand binding experiments, BRL37344 concentration-dependently displaced the specific binding of [(3)H] N-methyl scopolamine to muscarinic receptors on rat urinary bladder smooth muscle membranes. Additionally, BRL37344 inhibited [(3)H] N-methyl scopolamine binding to cloned human muscarinic receptors (M(1)-M(5)) expressed in Chinese hamster ovary cells. These results suggest that BRL37344 attenuates muscarinic receptor-mediated contractions through prevention of the agonists binding to their receptors, in addition to stimulation of beta(3)-adrenoceptors, in rat urinary bladder.
MaxiK channel, the large-conductance Ca2+-sensitive K+ channel, facilitates a negative feedback mechanism to oppose excitation and contraction in various types of smooth muscles including urinary bladder smooth muscle (UBSM). In this study, we investigated how the contribution of MaxiK channel to the regulation of basal UBSM mechanical activity is altered in streptozotocin-induced diabetic rats. Although the urinary bladder preparations from both control and diabetic rats were almost quiescent in their basal mechanical activities, they generated spontaneous rhythmic contractions in response to a MaxiK channel blocker, iberiotoxin (IbTx). The effect of IbTx on the mechanical activity was significantly greater in diabetic rat than in control animal. Similarly, the basal mechanical activity was increased with apamin, an inhibitor for some types of small conductance Ca2+-sensitive K+ channels, and this effect was more pronounced for diabetic rat. However, in both control and diabetic animals, IbTx action was stronger than that of apamin. Diabetes also enhanced the responses to BayK 8644, an L-type Ca2+ channel agonist. The extent of this enhancement in diabetic bladder vs. control was, however, almost the same as that attained with IbTx. Expression levels for MaxiK channel as well as apamin-sensitive K+ channels and L-type Ca2+ channel were not altered by diabetes, when determined as their corresponding mRNA levels. These results indicate that diabetes can potentially increase the basal UBSM mechanical activity. However, in diabetic UBSM, the main negative-feedback system triggered by MaxiK channel is still preserved enough to counteract the possible enhancement of this smooth muscle mechanical activity.
In this study, we evaluated an inhibition model of luseogliflozin on sodium glucose co-transporter 2 (SGLT2). We also analyzed the binding kinetics of the drug to SGLT2 protein using [(3)H]-luseogliflozin. Luseogliflozin competitively inhibited human SGLT2 (hSGLT2)-mediated glucose uptake with a Ki value of 1.10 nM. In the absence of glucose, [(3)H]-luseogliflozin exhibited a high affinity for hSGLT2 with a Kd value of 1.3 nM. The dissociation half-time was 7 h, suggesting that luseogliflozin dissociates rather slowly from hSGLT2. These profiles of luseogliflozin might contribute to the long duration of action of this drug.
Matrix
metalloproteinase-2 (MMP2) is a zinc-dependent endopeptidase
that plays important roles in the degradation of extracellular matrix
proteins. MMP2 is considered to be an attractive target for the treatment
of various diseases such as cancer, arthritis, and fibrosis. In this
study, we have developed a novel class of MMP2-selective inhibitors
by hybridizing the peptide that binds to a zinc ion and S2–S5
pockets with small molecules that bind to the S1′ pocket. Structural
modifications based on X-ray crystallography revealed that the introduction
of 2,4-diaminobutanoic acid (Dab) at position 4 dramatically enhanced
MMP2 selectivity by forming an electrostatic interaction with Glu130.
After improving the metabolic and chemical stability, TP0556351 (9) was identified. It exhibited potent MMP2 inhibitory activity
(IC50 = 0.20 nM) and extremely high selectivity. It suppressed
the accumulation of collagen in a bleomycin-induced idiopathic pulmonary
fibrosis model in mice, demonstrating the efficacy of MMP2-selective
inhibitors for fibrosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.